MDR-TB Close Contacts Tracing in China (TCCT Study)
NCT04484129 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2020-07-23
Summary
To investigate the incidence of etiologically confirmed or clinically diagnosed active tuberculosis in close contacts of MDR-TB patients.
Conditions
- Multidrug Resistant Tuberculosis
Sponsors & Collaborators
-
Huashan Hospital
lead OTHER
Principal Investigators
-
Wenhong Zhang, PhD · Huashan Hospital
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-07-21
- Primary Completion
- 2022-12-31
- Completion
- 2022-12-31
Countries
- China
Study Locations
More Related Trials
-
Identifcation of Biomarkers for Active Pulmonary Tuberculosis
NCT04490746 ·Status: UNKNOWN
-
Clinical Study on Adoptive Treatment of MDR-TB With Allogeneic γδT Cells
NCT03575299 ·Status: UNKNOWN ·Phase: PHASE1
-
Safety and Effectiveness of Delamanid-containing Regimen for MDR-TB Patients in China
NCT04421495 ·Status: UNKNOWN ·Phase: PHASE4
-
Determining Risk in Latent Tuberculosis
NCT01571739 ·Status: TERMINATED
-
Ultralow Dose Computed Tomography in High-risk Drug-resistant Tuberculosis Contacts
NCT02454738 ·Status: COMPLETED ·Phase: NA
-
Optimizing(O) RIfapentine-based(RI) Regimen and shortENing(EN) the Treatment of Drug-sensitive Tuberculosis(T)
NCT05401071 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
The Epidemiology of TST Change in Korea
NCT01850043 ·Status: COMPLETED
-
Drug Concentrations in the Treatment of MDR-TB Related to Minimum Inhibitory Concentrations
NCT02816931 ·Status: COMPLETED
-
TB YOUTH - TB sYstemic Management Using One-month, Ultra-short TPT Regimen for scHool Contacts
NCT06022146 ·Status: RECRUITING ·Phase: PHASE3
-
Asymptomatic TB With Innovative Modified Short-course Regimens
NCT06153069 ·Status: RECRUITING ·Phase: PHASE4
-
The Effect of 18-month Regimen Containing 6 Anti-tuberculosis Drugs for Patients With MDR-TB
NCT03830671 ·Status: COMPLETED ·Phase: PHASE4
-
A Retrospective Study on the Treatment Pattern and Clinical Prognosis of Severe Tuberculosis Patients
NCT06021041 ·Status: UNKNOWN
-
Shortened Regimens for Drug-susceptible Pulmonary Tuberculosis
NCT02901288 ·Status: UNKNOWN ·Phase: PHASE4
-
Training Protocol on the Natural History of Tuberculosis
NCT01212003 ·Status: RECRUITING
-
Refining MDR-TB Treatment (T) Regimens (R) for Ultra(U) Short(S) Therapy(T)-PLUS
NCT04717908 ·Status: COMPLETED ·Phase: NA
-
Multi-Drug Resistant Tuberculosis in Korea
NCT00341601 ·Status: COMPLETED
-
A Multicentre, Cohort Study of Screening and Preventive Intervention for Latent Tuberculosis Infection in Children
NCT04156568 ·Status: UNKNOWN ·Phase: PHASE1
-
Expression of Tuberculosis in the Lung
NCT00201253 ·Status: COMPLETED
-
A Retrospective Study of Treatment Patterns and Clinical Outcomes in Patients With Central Nervous System Tuberculosis
NCT06011915 ·Status: COMPLETED
-
Phase I Clinical Protocol for Pre-evaluation of the Safety of BCG-PPD in Tuberculosis Patients
NCT04538911 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Evaluation of Host Biomarker-based Point-of-care Tests for Targeted Screening for Active TB
NCT03350048 ·Status: COMPLETED
-
Clinic-based Versus Hotspot-focused Active TB Case Finding
NCT05285202 ·Status: RECRUITING ·Phase: NA
-
A Cluster-Randomized Trial of DOTS vs DOTS Plus Active Case Finding
NCT00414882 ·Status: COMPLETED
-
The Impact of Malnutrition on Immune Responses to Tuberculosis
NCT05044910 ·Status: ACTIVE_NOT_RECRUITING
-
Use TST and QFT-RD1 Test to Monitor the Tuberculous Infection in Patients, Close Contact People and Health Care Workers
NCT00311220 ·Status: UNKNOWN ·Phase: PHASE4